穿戴式心臟設備市場規模、佔有率和成長分析：按設備類型、應用、技術、最終用戶和地區分類－2026-2033年產業預測

2024 年全球穿戴式心臟監測設備市場價值為 35.2 億美元，預計到 2025 年將成長至 38.8 億美元，到 2033 年將成長至 85.2 億美元，在預測期（2026-2033 年）內複合年成長率為 10.32%。

穿戴式心臟設備市場正經歷顯著成長，這主要得益於心血管疾病發病率的上升、遠端患者監護的日益普及以及生物感測器技術的進步。遠端醫療的擴展和對持續心臟監測的需求進一步鞏固了市場格局。有利的報銷政策和監管核准，以及大規模篩檢和慢性病管理的推進，都促進了銷售額的穩定成長。儘管心電圖貼片、智慧型手錶和遠端心電圖監測器在醫療環境中的應用推動了市場需求，但對生物感測器和雲端技術的持續研究正在提升監測能力。然而，高成本、資料隱私問題、測量誤差風險以及監管障礙等挑戰可能會阻礙未來的市場滲透。

全球穿戴式心臟設備市場按設備類型、應用、技術、最終用戶和地區進行細分。依裝置類型分類，市場分為心電圖監測、心臟心臟事件記錄器、植入式循環記錄器和穿戴式心臟去心房顫動（WCD）。依應用分類，市場分為心律不整檢測、心房顫動監測和心臟衰竭管理。依技術分類，市場分為藍牙技術和蜂窩網路技術。依最終用戶分類，市場分為醫院、循環系統診所和居家照護。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球穿戴式心臟設備市場的成長要素

全球穿戴式心臟設備市場的主要促進因素之一是心血管疾病盛行率的不斷上升，這推動了對持續監測解決方案的需求成長。隨著人們對心臟健康的認知不斷提高，患者和醫療專業人員越來越傾向於尋求能夠實現即時數據收集和分析的創新技術。穿戴式裝置能夠及早發現潛在異常並促進及時干預，顯著改善患者的治療效果。此外，小型化和與行動應用程式整合等技術進步正在提升用戶體驗，並加速穿戴式心臟裝置在更廣泛患者群體中的普及。

全球穿戴式心臟設備市場的限制因素

全球穿戴式心臟設備市場的主要限制因素之一是先進技術的高成本和有限的保險報銷選擇。許多尖端的穿戴式心臟設備雖然創新，但價格昂貴，令許多患者難以負擔。此外，不同地區的報銷政策存在不確定性，阻礙了醫療機構全​​面採用這些設備。這種經濟障礙會阻礙穿戴式心臟設備的廣泛應用，尤其是在發展中市場，因為在這些市場，價格承受能力和保險覆蓋範圍仍然是關鍵問題。因此，這些經濟限制因素可能會減緩市場成長。

全球穿戴式心臟設備市場趨勢

全球穿戴式心臟設備市場正呈現出顯著的趨勢，將這些設備與遠端醫療生態系統融合，從而增強遠距監測並簡化醫療專業人員的工作流程。這種對互通性和資料安全的重視對於提供協調一致的醫療服務和及時做出臨床決策至關重要。透過將穿戴式裝置置於心臟護理流程的核心，各公司正在促進穿戴式科技供應商與虛擬醫療平台之間的合作。這些夥伴關係不僅旨在提高病患參與度，還旨在建立支持全面、長期照護管理的服務模式，這體現了心臟健康監測和管理方式的變革性轉變。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球穿戴式心臟設備市場規模：以設備類型分類

• 心電圖監測
• 心臟心臟事件記錄器
• 植物型循環記錄器
• 穿戴式心臟去心房顫動（WCD）

全球穿戴式心臟設備市場規模：按應用領域分類

• 心律不整檢測
• 心房顫動監測
• 心臟衰竭管理

全球穿戴式心臟設備市場規模：按技術分類

• 藍牙相容
• 相容蜂窩網路

全球穿戴式心臟設備市場規模：依最終用戶分類

• 醫院
• 循環系統診所
• 居家照護

全球穿戴式心臟設備市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• iRhythm Technologies
• Zoll Medical（Asahi Kasei）
• BioTelemetry（Philips）
• Medtronic plc
• Abbott Laboratories
• Boston Scientific
• CardioNet（BioTelemetry）
• GE Healthcare
• Biobeat Technologies
• AliveCor（KardiaMobile）
• SHL TeleMedicine
• VitalConnect
• Preventice Solutions
• InfoSonics Corporation
• Cardiac Science

結論與建議

Global Wearable Cardiac Devices Market size was valued at USD 3.52 Billion in 2024 and is poised to grow from USD 3.88 Billion in 2025 to USD 8.52 Billion by 2033, growing at a CAGR of 10.32% during the forecast period (2026-2033).

The wearable cardiac devices market is experiencing significant growth driven by the rising incidence of cardiovascular diseases, an increased emphasis on remote patient monitoring, and advancements in biosensor technologies. The expansion of telemedicine and the demand for continuous cardiac monitoring further enhance the market landscape. Supportive reimbursement policies and regulatory approvals, along with initiatives for population screening and chronic disease management, contribute to steady sales. The use of ECG patches, smartwatches, and remote heart monitors in healthcare settings propels demand, while ongoing research in biosensors and cloud technology enhances monitoring capabilities. However, challenges such as high costs, data privacy concerns, the risk of inaccuracies, and regulatory hurdles may hinder market penetration moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Wearable Cardiac Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Wearable Cardiac Devices Market Segments Analysis

Global wearable cardiac devices market is segmented by device type, application, technology, end-user,and region. Based on device type, the market is segmented into holter monitors, cardiac event monitors, implantable looprecorders,and wearable cardioverter defibrillators (WCD). Based on application, the market is segmented into arrhythmia detection, atrial fibrillation monitoring,and heart failure management. Based on technology, the market is segmented into Bluetooth-enabled and cellular-enabled. Based on end-user, the market is segmented into hospitals, cardiology clinics,and home care. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America,and Middle East & Africa.

Driver of the Global Wearable Cardiac Devices Market

One of the key market drivers for the global wearable cardiac devices market is the increasing prevalence of cardiovascular diseases, which has led to a heightened demand for continuous monitoring solutions. As awareness of heart health grows, patients and healthcare providers are seeking innovative technologies that allow for real-time data collection and analysis. Wearable devices enable early detection of potential anomalies and facilitate timely interventions, significantly improving patient outcomes. Additionally, advancements in technology, such as miniaturization and integration with mobile applications, enhance user experience and promote the adoption of wearable cardiac devices among a broader demographic of patients.

Restraints in the Global Wearable Cardiac Devices Market

One significant market restraint for the global wearable cardiac devices market is the high cost of advanced technology and limited reimbursement options. Many cutting-edge wearable cardiac devices, while innovative, come with steep price tags, making them less accessible to a broader patient population. Additionally, varying reimbursement policies across regions create uncertainty, deterring healthcare providers from fully adopting these devices. This financial barrier can hinder the widespread utilization of wearable cardiac devices, particularly in developing markets where affordability and insurance coverage remain critical challenges. As a result, the market may experience slower growth due to these economic limitations.

Market Trends of the Global Wearable Cardiac Devices Market

The Global Wearable Cardiac Devices market is witnessing a notable trend towards the integration of these devices with telehealth ecosystems, facilitating enhanced remote monitoring and streamlined clinician workflows. This focus on interoperability and data security is critical for delivering coordinated care and timely clinical decision-making. By placing wearable devices at the core of cardiac care pathways, companies are fostering collaborations between wearable technology providers and virtual care platforms. Such partnerships aim to create service models that not only boost patient engagement but also support comprehensive longitudinal care management, reflecting a transformative shift in how cardiac health is monitored and managed.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Wearable Cardiac Devices Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Holter Monitors
• Cardiac Event Monitors
• Implantable Loop Recorders
• Wearable Cardioverter Defibrillators (WCD)

Global Wearable Cardiac Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Arrhythmia Detection
• Atrial Fibrillation Monitoring
• Heart Failure Management

Global Wearable Cardiac Devices Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Bluetooth-Enabled
• Cellular-Enabled

Global Wearable Cardiac Devices Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiology Clinics
• Home Care

Global Wearable Cardiac Devices Market Size & CAGR (2026-2033)

• North America (Device Type, Application, Technology, End-User)
  • US
  • Canada
• Europe (Device Type, Application, Technology, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Device Type, Application, Technology, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Device Type, Application, Technology, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, Application, Technology, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• iRhythm Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoll Medical (Asahi Kasei)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTelemetry (Philips)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioNet (BioTelemetry)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biobeat Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AliveCor (KardiaMobile)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SHL TeleMedicine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VitalConnect
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Preventice Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InfoSonics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations